ABSTRACT
The idea behind biostructure-based drug design is to utilize the information on shape and properties of the binding site of a target molecule (e.g., enzyme or receptor) to design compounds which possess complementary properties. Thus, biostructure-based drug design requires methods for determination of the 3D structure of the target molecules as well as knowledge of which molecular interactions are important for obtaining the desired binding characteristics.
